Home Healthcare Medical Devices Neurovascular Devices Market

Neurovascular Devices Market Size, Share & Trends Analysis Report By Product (Embolization Devices, Revascularization Devices Inactivated Vaccines, Thrombectomy Devices, Embolic Protection Devices, Accessory Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR4172DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Neurovascular Devices Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Embolization Devices
    2. Revascularization Devices Inactivated Vaccines
    3. Thrombectomy Devices
    4. Embolic Protection Devices
    5. Accessory Devices
  2. Neurovascular Devices Market, By Disease Pathology 2022-2034 (USD MILLION/ Units)
    1. Aneurysm
    2. Arteriovenous Malformation and Fistulas (AVM)
    3. Ischemic Stroke
    4. Stenosis
    5. Others
  3. Regional Neurovascular Devices Market
    1. North America
      1. North America Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. North America Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. U.S. Neurovascular Devices Market
        1. U.S. Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. U.S. Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      4. Canada Neurovascular Devices Market
        1. Canada Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Canada Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
    2. Europe
      1. Europe Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. Europe Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. U.K. Neurovascular Devices Market
        1. U.K. Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. U.K. Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      4. Germany Neurovascular Devices Market
        1. Germany Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Germany Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      5. France Neurovascular Devices Market
        1. France Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. France Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      6. Spain Neurovascular Devices Market
        1. Spain Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Spain Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      7. Italy Neurovascular Devices Market
        1. Italy Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Italy Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      8. Russia Neurovascular Devices Market
        1. Russia Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Russia Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      9. Nordic Neurovascular Devices Market
        1. Nordic Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Nordic Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      10. Benelux Neurovascular Devices Market
        1. Benelux Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Benelux Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      11. Rest of Europe Neurovascular Devices Market
        1. Rest of Europe Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Rest of Europe Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
    3. APAC
      1. APAC Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. APAC Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. China Neurovascular Devices Market
        1. China Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. China Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      4. Korea Neurovascular Devices Market
        1. Korea Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Korea Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      5. Japan Neurovascular Devices Market
        1. Japan Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Japan Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      6. India Neurovascular Devices Market
        1. India Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. India Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      7. Australia Neurovascular Devices Market
        1. Australia Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Australia Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      8. Taiwan Neurovascular Devices Market
        1. Taiwan Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Taiwan Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      9. South East Asia Neurovascular Devices Market
        1. South East Asia Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. South East Asia Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      10. Rest of Asia-Pacific Neurovascular Devices Market
        1. Rest of Asia-Pacific Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Rest of Asia-Pacific Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
    4. Middle East and Africa
      1. Middle East and Africa Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. Middle East and Africa Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. UAE Neurovascular Devices Market
        1. UAE Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. UAE Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      4. Turkey Neurovascular Devices Market
        1. Turkey Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Turkey Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      5. Saudi Arabia Neurovascular Devices Market
        1. Saudi Arabia Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Saudi Arabia Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      6. South Africa Neurovascular Devices Market
        1. South Africa Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. South Africa Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      7. Egypt Neurovascular Devices Market
        1. Egypt Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Egypt Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      8. Nigeria Neurovascular Devices Market
        1. Nigeria Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Nigeria Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      9. Rest of MEA Neurovascular Devices Market
        1. Rest of MEA Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Rest of MEA Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
    5. LATAM
      1. LATAM Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. LATAM Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. Brazil Neurovascular Devices Market
        1. Brazil Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Brazil Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      4. Mexico Neurovascular Devices Market
        1. Mexico Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Mexico Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      5. Argentina Neurovascular Devices Market
        1. Argentina Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Argentina Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      6. Chile Neurovascular Devices Market
        1. Chile Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Chile Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      7. Colombia Neurovascular Devices Market
        1. Colombia Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Colombia Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
      8. Rest of LATAM Neurovascular Devices Market
        1. Rest of LATAM Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
          1. Embolization Devices
          2. Revascularization Devices Inactivated Vaccines
          3. Thrombectomy Devices
          4. Embolic Protection Devices
          5. Accessory Devices
        2. Rest of LATAM Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
          1. Aneurysm
          2. Arteriovenous Malformation and Fistulas (AVM)
          3. Ischemic Stroke
          4. Stenosis
          5. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.